Skip to main content

Table 8 Multivariate logistic regression for the composite effectiveness outcomes (symptomatic/non-symptomatic DVT up to POD10 and PE up to POD28) in patients receiving THA

From: Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study

Predictors

Odds ratio

95% CI

P value

Age, ≧75 years

1.82

1.15-2.87

0.011

Female gender

2.31

1.03-5.18

0.041

e-GFR, <60 mL/min per 1.73 m2

0.81

0.44-1.50

0.502

Body mass index, ≧30 kg/m2

0.89

0.36-2.20

0.803

General anesthesia

0.41

0.23-0.71

0.002

Operation time, ≧120 minutes

0.79

0.50-1.23

0.293

Use of foot pump

1.08

0.59-1.96

0.808

Use of elastic stocking

0.51

0.26-1.01

0.052

Medications

   

  Unfractionated heparin

1.27

0.44-3.61

0.658

  Enoxaparin

0.84

0.44-1.57

0.577

  Fondaparinux

0.36

0.20-0.66

0.001

  Others

1.36

0.55-3.36

0.502

  1. CI, confidence interval; DVT, deep vein thrombosis; e-GFR, estimated glomerular filtrating ratio; PE, pulmonary embolism; THA, total hip arthroplasty.